APOE4, the leading genetic risk factor for Alzheimer's, harmed flies only under oxidative stress or a high-sugar diet, accelerating age-related decline in memory, taste, and gut barrier
APOE4, the leading genetic risk factor for Alzheimer's, harmed flies only under oxidative stress or a high-sugar diet, accelerating age-related decline in memory, taste, and gut barrier
Biologists at Texas A&M University replaced the Drosophila lipid-transport gene GLaz with human APOE3 or APOE4. On standard food, APOE4 flies lived just as long as APOE3 flies. After exposure to rotenone, which induces oxidative stress, or to a high-sugar diet, however, APOE4 flies showed earlier deterioration of memory, taste sensitivity, and intestinal barrier integrity, along with a greater reduction in lifespan than APOE3 flies. The work was posted on September 12 on bioRxiv, an archive where papers are published before peer review.
APOE is a protein that transports lipids and cholesterol in the brain: astrocytes, the glial cells that support neurons, produce it, and neurons themselves take it up. APOE4 differs from the lower-risk APOE3 by just one amino acid, yet it is found in nearly three out of four Alzheimer's patients. The risk is statistical: some carriers reach old age without a diagnosis, and some patients who develop the disease do not carry the variant at all. For decades it has remained unclear what converts this elevated risk into actual disease.
To investigate, the authors used a precise approach: human APOE3 or APOE4 replaced GLaz and operates in the same cells and at the same expression level as the native fly gene. This distinguishes the model from earlier Drosophila models of Alzheimer's, where the human protein was added at elevated doses, making it impossible to tell whether the damage came from the variant itself or from overexpression.
The picture changed when a subset of flies was transferred to food containing rotenone, a compound that disrupts mitochondria and generates oxidative stress (the same method used in rodents to model Parkinson's disease). In APOE3 flies, rotenone shortened lifespan only modestly. In APOE4 flies, it sharply reduced lifespan and accelerated age-related decline in other functions: by day 20, their sensitivity to sweet taste had deteriorated, memory for bitter taste had weakened, and the intestinal wall had become permeable to ingested dye. None of this was seen in five-day-old flies of either variant or in APOE3 flies at any age.
A similar pattern emerged under a different challenge: a diet with excess sugar, which in flies causes obesity and insulin resistance analogous to type 2 diabetes in humans. Lifespan was shortened in flies of both variants, but substantially more so in APOE4 flies, and by day 20 their taste response and memory had declined more steeply as well. In APOE3 flies on the same diet, the changes remained considerably milder. The convergence of results under two dissimilar types of stress points to an intrinsic property of the gene itself: reduced resilience to cellular and metabolic load regardless of its source.
The authors tie this to the direct function of APOE: under normal conditions, it picks up oxidized lipids that overburdened neurons release and delivers them to glia, which store these toxic lipids in protective lipid droplets away from nerve cells. Rotenone, by destroying mitochondria, strikes precisely at this step: it sharply increases the release of such lipids, and APOE4 handles the resulting surge less effectively than APOE3. This fits longstanding observations in humans: obesity, diabetes, and other forms of oxidative and metabolic stress independently raise the risk of Alzheimer's in APOE4 carriers.
This kind of protection has already been observed in human neurons: the protective variant of the same gene, APOE2, when added to APOE4 cells, reduced the DNA damage signal after irradiation. A fly lives for weeks rather than the months required to culture neurons, and it could become a fast model for screening such compounds, a task that takes years in mice.